Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for prevention of anthracycline-associated diastolic dysfunction
IRCT20250514065739N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in diastolic dysfunction comparing Ranolazine arm with Placebo arm (2 arms). Primary endpoint: Diastolic cardiac function in echocardiography. Started Jun 2025; status: completed.
02
Drugs
ranolazine
03
Conditions
diastolic dysfunction
Beyond the preview
Go deeper on IRCT20250514065739N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250514065739N1.